Lawmakers investigate Vytorin ad campaign

01/16/2008 | Bloomberg

U.S. Reps. John Dingell and Bart Stupak asked the FDA and Vytorin developers Schering-Plough Corp. and Merck & Co. to submit documentation on the $200-million consumer ad campaign for the cholesterol drug, following the release of study results casting doubt on the drug's efficacy. The companies have said they are cooperating with the investigation.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Media

Job Title Company Location
Director, Industry Initiatives (Digital Video and AdvancedTV)
Interactive Advertising Bureau
New York, NY
Digital Ad Operations Specialist
Crain Communications
Nationwide, SL_Nationwide
Senior Manager, Marketing
IAB
New York, NY